Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis. Thouvenot E, Carlander B, Camu W Expert Rev Neurother. 2012 Nov 11. PMID: 23140228. Abstract CommentRecommendBookmarkWatch